NCT02293876 (CORNEALPREV) is a NA clinical trial of LACRIBELL® in Keratitis, sponsored by Hospital Risoleta Tolentino Neves.

Who is sponsoring NCT02293876?

NCT02293876 is sponsored by Hospital Risoleta Tolentino Neves.

What drugs are being tested in NCT02293876?

Interventions in NCT02293876: LACRIBELL®, LIPOSIC®, Glad wrap.

What condition does NCT02293876 study?

NCT02293876 studies Keratitis, Corneal Ulcer.

Is NCT02293876 still recruiting?

NCT02293876 is currently completed. Last updated 18 November 2014.

Last reviewed 2014-11-18 · How we verify

NCT02293876: CORNEALPREV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk for Corneal Injury in Critically Ill Patients and Effect of Nursing Interventions for Its Prevention: Randomized Controlled Trial

Completed NA Last updated 18 November 2014

What this trial tests

NA trial testing LACRIBELL® in Keratitis in 360 participants. Completed in 1 November 2014.

Timeline

1 April 2013

Primary endpoint
1 April 2014

1 November 2014

Quick facts

Lead sponsor	Hospital Risoleta Tolentino Neves
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	prevention
Enrollment	360
Start date	1 April 2013
Primary completion	1 April 2014
Estimated completion	1 November 2014
Sites	1 location across Brazil

Drugs / interventions tested

LACRIBELL®
LIPOSIC®
Glad wrap

Conditions studied

Keratitis — all drugs for Keratitis →
Corneal Ulcer — all drugs for Corneal Ulcer →

Sponsor

Hospital Risoleta Tolentino Neves

Who can join

Adults 18 to 93, any sex, with Keratitis or Corneal Ulcer. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Keratitis
Time frame: Five days
Presence of keratitis visible with a cobalt light ophthalmoscope and fluorescein eye drop.

Sponsor's own description

The purpose of the study is find out the better measure to achieve corneal protection in an Intensive Care Unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of LACRIBELL®

Trials testing the same drug.

NCT02767258 — Effect of Nursing Care on Prevention of Dry Eye · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02293876 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Risoleta Tolentino Neves
Last refreshed: 18 November 2014

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02293876.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing